Combined in silico and in vitro approach to drug screening

Croatica Chemica Acta

Volumn 78, Issue 2, 2005, Pages 133-139

  Verbanac, Donatella ^a   Jelić, Dubravko ^a   Stepanić, Višnja ^a   Tatić, Iva ^a   Žiher, Dinko ^a   Koštrun, Sanja ^a  

^a PLIVA Research Institute Ltd   (Croatia)

Author keywords

Clustering; Compounds library; Drug discovery; In silico; In vitro; Screening

Indexed keywords

DRUG; FORMAZAN;

BACTERIAL CELL; BIOASSAY; BIOINFORMATICS; CHEMICAL STRUCTURE; CONFERENCE PAPER; DATA BASE; DRUG INDUSTRY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTRATION; FUNGUS GROWTH; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; PROTEIN INTERACTION; PROTEIN TARGETING;

EID: 21044442734     PISSN: 00111643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. J. C. Venter et al., Science 291 (2001) 1304-1351.
2. . F. Darvas, G. Keserû, Á. Papp, G. Dormán, L. Ürge, and P. Krajcsi, Curr. Top. Med. Chem. 2 (2002) 1287-1304.
3. A. R. Leach and M. M. Hann, DDT 5 (2000) 326-336.
4. Daylight Chemical Information Systems, Inc., http://www.day-light.com
5. C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Adv. Drug Del. Rev. 23 (1997) 3-25.
6. A. K. Ghose, V. N. Viswanadhan, and J. J.Wendoloski, J. Phys. Chem. 102 (1998) 3762-3772.
7. J. F. Blake, BioTechniques 34 (2003) 16-20.
8. D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, and K. D. Kopple, J. Med. Chem. 45 (2002) 2615-2623.
9. H. van de Waterbeemd, Cur. Opin. Drug Discov. Devel. 5 (2002) 33-43.
10. H. van de Waterbeemd and E. Gifford, Nature 2 (2003) 192-204.
11. D. E. Clark and P. D. J. Grootenhuis, Cur. Top. Med. Chem. 3 (2003) 1193-1203.
12. J. E. Penzotti, G. A. Landrum, and S. Putta, Cur. Opin. Drug Disc. Dev. 7 (2004) 49-61.
13. T. J. Hou, W. Zhang, K. Xia, X. B. Qiao, and X. J. Xu, J. Chem. Inf. Comp. Sci. 44 (2004) 1585-1600.
14. V. Meunier, M. Bourrié, Y. Berger, and G. Fabre, Cell Biol. Toxicol. 11 (1995) 187-194.
15. T. Hou and X. Xu, J. Mol. Model. 8 (2002) 337-349.
16. G. Cruciani, P. Crivori, P.-A. Carrupt, and B. Testa, J. Mol. Struct. (Theochem) 503 (2000) 17-30.
17. E. M. Duffy and W. L. Jorgensen, J. Am. Chem. Soc. 122 (2000) 2878-2888.
18. Accelrys, Inc., http://www.accelrys.com
19. J. H. van Drie and M. S. Lajines, DDT 3 (1998) 274-283.
20. D. Gorse, A. Rees, M. Kaczorek, and R. Lahana, DDT 4 (1999) 257-264.
21. N. Nikolova and J. Jaworska, QSAR Comb. Sci. 22 (2003) 1006-1026.
22. D. E. Patterson, R. D. Cramer, A. M. Ferguson, R. D. Clark, and L. E. Weinberger, J. Med. Chem. 39 (1996) 3049-3059.
23. Y. C. Martin, J. L. Kofron, and L. M. Traphagen, J. Med. Chem. 45 (2002) 4350-4358.
24. R. P. Sheridan and S. K. Kearsley, DDT 7 (2002) 903-911.
25. R. A. Jarvis, IEEE Trans. Comput. C-22 (1973) 7025-1034.
26. D. Butina, J. Chem. Inf. Comput. Sci. 39 (1999) 747-750.
27. J. Bajorath, Nat. Rev. Drug Discov. 1 (2002) 882-894.
28. H. Kubinyi, Nat. Rev. Drug Discov. 2 (2003) 665-668.
29. B. Waszkowycz, T. D. J. Perkins, R. A. Sykes, and J. Li, IBM Systems Journal 40 (2001) 360-378.
30. P. Pospisil, P. Ballmer, L. Scapozza, and G. Folkers, J. Recept Signal Transduct Res. 23 (2003) 361-371.
31. Molecular Networks GmbH, http://www.mol-net.de/software/tautomer
32. http://www.tripos.com/sciTech/inSilicoDisc/media/LITCTR/SPLEXPS.PDF
33. R. S. Pearlman, Chem. Design Autom. News 2 (1987) 5-7.
34. A. Rusinko, R. Sheridan, R. Nilakantan, K. Haraki, N. Bauman, and R. Venkataraghavan, J. Chem. Inf. Comput. Sci. 29 (1989) 251-255.
35. J. Gasteiger, C. Rudolph, and J. Sadowski, Tetrahedron Comp. Method. 3 (1990) 537-547.
36. P. D. Lyne, DDT 7 (2002) 1047-1055.
37. B. K. Shoichet, S. L. McGovern, B. Wei, and J. J. Irwin, Curr. Opin. Chem. Biol. 6 (2002) 439-446.
38. X. Chen, Z. L. Ji, and Y. Z. Chen, Nudeic Acids Res. 30 (2002) 412-415.
39. G. Jones, P. Willett, R. C. Glen, A. R. Leach, and R. Taylor, J. Mol. Biol. 267 (1997) 727-748.
40. H. Claussen, C. Buning, M. Rarey, and T. Lengauer, J. Mol. Biol. 308 (2001) 377-395.
41. M. Rarey, B. Kramer, T. Lengauer, and G. Klebe, J. Mol. Biol. 261 (1996) 470-489.
42. T. J. Ewing, S. Makino, A. G. Skillman, and I. D. Kunz, J. Comput.-Aided Mol. Des. 15 (2001) 411-428.
43. http://www.bio.vu.nl/nvtb/Docking.html
44. D. Jelić, V. Mesar, I. Bašic, D. Nadramija, and D. Verbanac, PharmaChem 6 (2003) 64-67.
45. National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A5, 5th ed., National Committee for Clinical Laboratory Standards, Wayne, Pa., 2000.
46. K. Slater, Curr. Op. in Biotech. 12 (2001) 70-74.
47. T. Mosmann, J. Immunol. Meth. 65 (1983) 55-63.
48. S. J. Dexter, M. Camara, M. Davies, and K. M. Shakesheff, Biomaterials 24 (2003) 27-34.
49. S. Crouch, R. Kozlowski, K. Slater, and J. Fletcher, J. Immunol. Meth. 160 (1993) 81-88.
50. R. Seethala, Methods 22 (2000) 61-70.
51. J. R. Crowther, ELISA: Theory and Practice, in: J. M. Walker (Ed.), Methods in Molecular Biology, vol. 42, Humana Press Inc., Totowa, 1995.
52. B. Walsh and D. Henderson, J. Anim. Sci. 82 (2004) 292-299.